Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.34637 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.20368 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.41038 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.97313 | 74 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.24483 | 69 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.36902 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.33892 | 70 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.38898 | 70 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.26733 | 69 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.68335 | 73 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.95497 | 75 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.62862 | 72 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.52495 | 72 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.40709 | 71 |